CHS Inc. 8% Cumulative Redeemable Preferred Stock (CHSCP)
StalwartFairStock Score: 31/100 — RISKY
Key Financials
| Current Price | $27.9 |
| Market Cap | — |
| P/E Ratio | — |
| ROE | 4.98% |
| Dividend Yield | 7.21% |
| Sector | Consumer Defensive |
Strengths
- Conservative balance sheet with debt-to-equity of just 0.37, providing financial flexibility
- Attractive 7.2% dividend yield providing steady income returns
AI Analysis
CHS Inc. 8% Cumulative Redeemable Preferred Stock is a micro-cap consumer defensive company. Revenue stands at $35.6 billion. From a quality standpoint, CHS shows modest 5% ROE and conservative leverage at 0.37x debt-to-equity. The 7.2% dividend yield adds an income component for patient holders. Our composite FairStock Score of 31/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the consumer defensive space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer